Lindner Center of HOPE News

Lindner Center of HOPE Names Stacey Reese Program Manager of Sibcy House

July 27, 2016
Lindner Center of HOPE is pleased to announce that Stacey Reese, MSW, LISW-S, has been named Program Manager of Sibcy House at Lindner Center of HOPE. The program manager has 24-hour responsibility for high quality clinical care and services on the Sibcy milieu for Sibcy House patients. The position works collaboratively with Sibcy team members […]

Lindner Center of HOPE Rates Highly Amongst Referrers

July 13, 2016
Lindner Center of HOPE surveyed referral sources for its many programs and services in June 2016. Results of that survey indicated a high rate of satisfaction from those referring patients to Lindner Center of HOPE for mental health and addiction assessment and treatment. Approximately 130 referrers took the time to respond to the survey. An […]

Lindner Center of HOPE Announces Promotions within Medical Staff

June 29, 2016
Lindner Center of HOPE is pleased to announce the following changes to clinical administration: Paul R. Crosby, MD, Chief Medical Officer Tracy Suzanne Cummings, MD, Medical Director of Cincinnati Children’s Hospital Medical Center Inpatient and Partial Hospital Program at Lindner Center of HOPE C. Stephen Edwards, MD, Chief of Child and Adolescent Psychiatry and Medical […]

Williams House Announces New Medical Director

June 28, 2016
C. Stephen Edwards, MD, has been named Medical Director of Williams House at Lindner Center of HOPE. Dr. Edwards has been a member of Lindner Center of HOPE’s Medical Staff since opening, serving as Chief of Child and Adolescent Psychiatry and most recently Medical Director of the Harold C. Schott Foundation Eating Disorder Program and […]

Research Currently Underway at The Research Institute at Lindner Center of HOPE Could Lead to the Development of the First Diagnostic Test for People Struggling with Depressive Symptoms

March 28, 2016
The Research Institute at Lindner Center of HOPE is a site for an open label study with the primary goal of validating a signature (model) based on a panel of serum proteomic markers that discriminate Bipolar I, Bipolar II and Major Depression in people seeking treatment for a major depressive episode. The success of this […]